Phibro Animal Health PAHC
NASDAQ PAHC
$35.02 -0.95 (-2.64%)
At close: Nov 16, 2026 · 4:00 PM EST

Phibro Animal Health (PAHC) EBITDA Margin (2013 - 2026)

Updated

Phibro Animal Health's EBITDA Margin was 16.95% in fiscal Q1 2027 (quarter ended Sep 30, 2026), down 1.29 percentage points from 18.24% a year earlier but up 0.86 percentage points from the prior quarter.

Analysis

Phibro Animal Health (PAHC) EBITDA Margin (2013 - 2026) Analysis & Trends

On a trailing twelve-month basis, Phibro Animal Health's EBITDA Margin was 16.50% through Sep 30, 2026, up 2.00 percentage points year-over-year; for FY2026 (ended Jun 30, 2026), it was 16.80%, up 4.00 percentage points from FY2025.

  • EBITDA Margin shows a five-year change of +2.85 percentage points (FY2021 to FY2026).
  • In earlier fiscal years, EBITDA Margin was 12.80% in FY2025 (+2.96 pp), 9.85% in FY2024 (-2.05 pp), 11.89% in FY2023 (-0.97 pp) and 12.86% in FY2022 (-1.09 pp).
  • Quarterly EBITDA Margin has moved between 4.69% (fiscal Q1 2024) and 18.24% (fiscal Q1 2026) over five years.
  • Compared with a year earlier, EBITDA Margin was higher in seven of the last eight quarters, with an average year-over-year change of +2.59 percentage points.
  • The best year-over-year quarter for EBITDA Margin over five years was fiscal Q1 2026 (a gain of 6.98 percentage points); the worst was fiscal Q1 2024 (a drop of 5.93 percentage points).
  • Per Business Quant data, PAHC's EBITDA Margin in the three fiscal quarters before Q1 2027 was 16.09% (Q4 2026), 15.49% (Q3 2026) and 17.52% (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 36.69%
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 32.68%
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 46.88%
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 40.60%
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 39.77%
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 46.62%
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 50.63%
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 42.49%
10 Phibro Animal Health 1.42 Bn 1.11 Bn 128.54 Mn 16.95%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 16.95%
Jun 30, 2026 16.09%
Mar 31, 2026 15.49%
Dec 31, 2025 17.52%
Sep 30, 2025 18.24%
Jun 30, 2025 12.78%
Mar 31, 2025 13.92%
Dec 31, 2024 12.86%
Sep 30, 2024 11.26%
Jun 30, 2024 11.06%
Mar 31, 2024 12.08%
Dec 31, 2023 10.94%
Sep 30, 2023 4.69%
Jun 30, 2023 13.72%
Mar 31, 2023 12.07%
Dec 31, 2022 11.02%
Sep 30, 2022 10.61%
Jun 30, 2022 13.26%
Mar 31, 2022 12.53%
Dec 31, 2021 14.00%
API Access

Phibro Animal Health EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=PAHC&period=max&api_key=YOUR_API_KEY